Shypd.aiThe largest open index of AI tools
Ophthalytics Inc offers 360 Intelligent Diagnostics, an AI-based platform for early detection of diabetic retinopathy. It provides efficient and affordable retinal scan analysis, generating comprehensive reports in minutes.
Trending
About
Ophthalytics Inc, through its 360 Intelligent Diagnostics platform, is dedicated to advancing wellbeing using deep-learning AI for early disease detection. Their flagship product, Nsight360, focuses on identifying the risk of diabetic retinopathy, a critical and often undiagnosed condition. The platform ensures precision and efficiency by leveraging AI-powered assessments based on existing clinical practice guidelines. Nsight360 is camera-agnostic, working seamlessly with various stationary and portable cameras, and is designed for easy deployment, even in remote settings by non-specialized personnel. This approach aims to address significant care gaps, particularly among underserved communities, by making diagnostic imaging accessible and affordable. The company is also actively researching AI applications for early diagnosis of other diseases.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check 360intelligentdiagnostics.com for current pricing.
FAQs
Trending
